Ergo was Drdgold’s largest segment in fiscal 2026, bringing in $8.08B of $11.16B (72%).
| Segment | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | FY 2026 |
|---|---|---|---|---|---|---|---|---|
| Ergo | $4.11B | $4.52B | $5.67B | $8.08B | ||||
| Ergo Operations | — | — | — | — | ||||
| Fwgr | $1.39B | $1.71B | $2.21B | $3.08B | ||||
| Total | $5.50B | $6.24B | $7.88B | $11.16B |
Drdgold brought in $11.16B from its two segments in fiscal 2026, the year ended June 30, 2026. That was up 41.6% from $7.88B in fiscal 2025. Ergo was the largest at $8.08B (72.4%), ahead of Fwgr at $3.08B (27.6%).
Compared with fiscal 2025, Ergo grew 42.5% to $8.08B and Fwgr grew 39.5% to $3.08B. From fiscal 2023 to 2026, combined revenue from these segments grew from $5.50B to $11.16B, a compound annual growth rate of 26.6%. Ergo's share of the total fell from 74.8% to 72.4%.
Drdgold (DRD) reports its revenue by segment. In fiscal 2026, Ergo was its largest segment, bringing in $8.08B (72.4% of the total), followed by Fwgr at $3.08B (27.6%).
Ergo was Drdgold's largest segment in fiscal 2026, bringing in $8.08B, or 72.4% of the $11.16B total across its two segments.
Ergo grew faster than Fwgr in fiscal 2026, up 42.5% from $5.67B to $8.08B. Fwgr grew 39.5% to $3.08B.
Every figure comes from Drdgold's annual financial filings, as reported. Each line keeps the name Drdgold gives it, and years follow its fiscal calendar.
Drdgold's revenue by segment goes back to fiscal 2019, with figures through fiscal 2026. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.